Neoadjuvant combination therapy with trastuzumab in a breast cancer patient with synchronous rectal carcinoma: a case report and biomarker study

Neoadjuvant combination therapy with trastuzumab in a breast cancer patient with synchronous rectal carcinoma: a case report and biomarker study

We report a patient who presented with synchronous second primary human epidermal growth factor receptor (HER)-2-positive breast cancer and rectal cancer that both required simultaneous neoadjuvant therapy. A modified regimen combining anti-HER-2 monoclonal antibody trastuzumab with chemotherapy and...

Full description

Bibliographic Details
Main Authors: Vitásková Denisa, Melichar Bohuslav, Bartoušková Marie, Vlachová Zuzana, Vrána David, Janková Jana, Adam Tomáš, Juráňová Jarmila, Zlámalová Nora, Kujovská Krčmová Lenka, Javorská Lenka, Klos Dušan, Študentová Hana
Format: Article
Language:English
Published: De Gruyter 2017-12-01
Series:Pteridines
Subjects:
breast cancer
chemoradiation
neoadjuvant therapy
neopterin
trastuzumab
Online Access:https://doi.org/10.1515/pterid-2017-0017

Internet

https://doi.org/10.1515/pterid-2017-0017

Similar Items